Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Return on Assets (2022 - 2024)

Historic Return on Assets for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to 0.16%.

  • Addex Therapeutics' Return on Assets fell 4300.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 4300.0%. This contributed to the annual value of 1.57% for FY2024, which is 28700.0% up from last year.
  • Latest data reveals that Addex Therapeutics reported Return on Assets of 0.16% as of Q3 2025, which was down 4300.0% from 0.15% recorded in Q2 2025.
  • Over the past 5 years, Addex Therapeutics' Return on Assets peaked at 1.25% during Q1 2025, and registered a low of 3.61% during Q1 2024.
  • Its 4-year average for Return on Assets is 0.5%, with a median of 0.15% in 2025.
  • As far as peak fluctuations go, Addex Therapeutics' Return on Assets crashed by -27100bps in 2024, and later skyrocketed by 48600bps in 2025.
  • Over the past 4 years, Addex Therapeutics' Return on Assets (Quarter) stood at 1.08% in 2022, then plummeted by -141bps to 2.6% in 2023, then skyrocketed by 139bps to 1.0% in 2024, then crashed by -116bps to 0.16% in 2025.
  • Its Return on Assets stands at 0.16% for Q3 2025, versus 0.15% for Q2 2025 and 1.25% for Q1 2025.